At the Board of Directors meeting held on July 10, 2020, we resolved to acquire all issued shares of Cell Technology Co., Ltd., a wholly owned subsidiary of Gene Techno Science Co., Ltd., our business alliance partner, and make Cell Technology Co., Ltd our subsidiary. With the transfer of shares, Remcare Co., Ltd., a wholly owned subsidiary of Cell Technology Co., Ltd. will also become our subsidiary.

For details of this matter, please refer to the press release by Gene Techno Science Co., Ltd.